Brain zaps may tweak hormones: early study tests TMS on healthy women
NCT ID NCT07363421
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This small study tests whether transcranial magnetic stimulation (TMS), a non-invasive brain stimulation technique, can alter levels of luteinizing hormone (LH) and follicle-stimulating hormone (FSH) in healthy women. Ten women in the luteal phase of their menstrual cycle will receive both active and sham TMS to see if hormone levels change. It is a feasibility study, meaning it aims to see if the approach works at all, not to treat any disease.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Transcranial Magnetic Stimulation (TMS)
What this could lead to
If it works, this could point toward a non-invasive way to influence hormones, potentially helping with hormone-related conditions.
What could go wrong
This is a very small, early feasibility study in healthy women, not a treatment trial. It may not show any effect or translate to clinical use.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY WOMEN are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Site 1
New York, New York, 10010, United States